These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21566249)

  • 1. Pathophysiological basis of albumin use in cirrhosis.
    Arroyo V; Fernandez J
    Ann Hepatol; 2011 May; 10 Suppl 1():S6-14. PubMed ID: 21566249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatorenal syndrome.
    Guevara M; Ginès P
    Dig Dis; 2005; 23(1):47-55. PubMed ID: 15920325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Circulatory dysfunction syndrome associated with liver cirrhosis].
    Hartleb M
    Przegl Epidemiol; 2005; 59(2):549-58. PubMed ID: 16190566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial.
    Solà E; Solé C; Simón-Talero M; Martín-Llahí M; Castellote J; Garcia-Martínez R; Moreira R; Torrens M; Márquez F; Fabrellas N; de Prada G; Huelin P; Lopez Benaiges E; Ventura M; Manríquez M; Nazar A; Ariza X; Suñé P; Graupera I; Pose E; Colmenero J; Pavesi M; Guevara M; Navasa M; Xiol X; Córdoba J; Vargas V; Ginès P
    J Hepatol; 2018 Dec; 69(6):1250-1259. PubMed ID: 30138685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis.
    Møller S; Bendtsen F
    Liver Int; 2018 Apr; 38(4):570-580. PubMed ID: 28921803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.
    Arroyo V; Jiménez W
    J Hepatol; 2000; 32(1 Suppl):157-70. PubMed ID: 10728802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study.
    Hamdy H; ElBaz AA; Hassan A; Hassanin O
    J Clin Gastroenterol; 2014 Feb; 48(2):184-8. PubMed ID: 23842215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
    Appenrodt B; Wolf A; Grünhage F; Trebicka J; Schepke M; Rabe C; Lammert F; Sauerbruch T; Heller J
    Liver Int; 2008 Aug; 28(7):1019-25. PubMed ID: 18410283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study.
    Moreau R; Asselah T; Condat B; de Kerguenec C; Pessione F; Bernard B; Poynard T; Binn M; Grangé JD; Valla D; Lebrec D
    Gut; 2002 Jan; 50(1):90-4. PubMed ID: 11772973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic effects of plasma-expansion with hyperoncotic albumin in cirrhotic patients with renal failure: a prospective interventional study.
    Umgelter A; Wagner K; Reindl W; Nurtsch N; Huber W; Schmid RM
    BMC Gastroenterol; 2008 Aug; 8():39. PubMed ID: 18752670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albumin infusion may deleteriously promote extracellular fluid overload without improving circulating hypovolemia in patients of advanced cirrhosis with diabetes mellitus and sepsis.
    Kumar R; Kumar S; Lata S
    Med Hypotheses; 2013 Apr; 80(4):452-5. PubMed ID: 23375411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug insight: the role of albumin in the management of chronic liver disease.
    Wong F
    Nat Clin Pract Gastroenterol Hepatol; 2007 Jan; 4(1):43-51. PubMed ID: 17203088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial.
    Umgelter A; Reindl W; Wagner KS; Franzen M; Stock K; Schmid RM; Huber W
    Crit Care; 2008; 12(1):R4. PubMed ID: 18197961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology, diagnosis and treatment of ascites in cirrhosis.
    Arroyo V
    Ann Hepatol; 2002; 1(2):72-9. PubMed ID: 15115971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and Management of Liver Cirrhosis: Pathophysiology of Renal Dysfunction in Cirrhosis.
    Solà E; Ginès P
    Dig Dis; 2015; 33(4):534-8. PubMed ID: 26159270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis.
    Fernández J; Navasa M; Garcia-Pagan JC; G-Abraldes J; Jiménez W; Bosch J; Arroyo V
    J Hepatol; 2004 Sep; 41(3):384-90. PubMed ID: 15336440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.
    Moleda L; Trebicka J; Dietrich P; Gäbele E; Hellerbrand C; Straub RH; Sauerbruch T; Schoelmerich J; Wiest R
    Gut; 2011 Aug; 60(8):1122-32. PubMed ID: 21317421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noradrenaline and albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized pilot study.
    Singh V; Kumar B; Nain CK; Singh B; Sharma N; Bhalla A; Sharma AK
    J Intern Med; 2006 Jul; 260(1):62-8. PubMed ID: 16789980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current indications for the use of albumin in the treatment of cirrhosis.
    Alves de Mattos A
    Ann Hepatol; 2011 May; 10 Suppl 1():S15-20. PubMed ID: 21566250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
    Narahara Y; Kanazawa H; Taki Y; Kimura Y; Atsukawa M; Katakura T; Kidokoro H; Harimoto H; Fukuda T; Matsushita Y; Nakatsuka K; Sakamoto C
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.